All Type of News
SK Chemicals signs exclusive supply agreement of Parkinson’s treatment with Portuguese BIAL
SK Chemicals will supply treatments for Parkinson’s disease patients with motor fluctuation in Korea.
SK Chemicals announced on the 5th that the company has signed a license agreement of exclusive supply of ‘Ongentys...
Daewoong takes a lead for anticancer ‘Samfenet’ on behalf of Samsung Bioepis
Daewoong Pharmaceutical(CEO Jong-Wook Lee) announced the company would launch ‘Samfenet,’ a Samsung Bioepis’ trastuzumab biosimilar on the 5th in Korea. Samfenet acquired approval from the Korean Ministry of Food and ...
“Korean pharmaceutical industry with mobility will join ‘AI soceity’”
It was anticipated the Korean pharmaceutical industry might be able to become one of the advanced pharmaceutical power in developing new drugs using AI(artificial intelligence) with their strong point called ‘mobility...
Medicine trade balance was USD 354.5 million this January
The medicine trade balance reportedly recorded USD 354.5 million deficits this January.
According to the 2018 January Import and Export Status published by the Korea Customs Service, Korea exported USD 252.9 million ...
Endless supply suspensions and shortages of medicines even this March
There have been an endless series of drug shortages caused by supply suspension or manufacturing suspension even this March.
The industry concerned showed Ticlodone Tab 100mg and 200mg Sanofi Aventis Korea is distrib...
Pharmacies, “We are more worried about loss of employees than personnel expenses”
The pharmacy society seems settled now as experiencing a chaos from the personnel expense issue, caused by the increase of the minimum salary to KRW 7,530, before.
According to the society, pharmacy owners have repor...
“It is necessary to have effective IT management platform even in health care field”
It was suggested it would be necessary to have an efficient platform to manage administrative and personnel affairs using the information technology even in the health care field.
AcuteNet CEO Fariba Anderson stresse...
“No damages will be created in the medical field by the Moon Jae-In Care”
The Ministry of Health and Welfare has put on a drive for the Moon Jae-In Care as preparing for agreements with the medical field after collecting opinions from the Korean Medical Association’s(KMA) Emergency Operatio...
U.S. FDA starts to review NDA of SK Biopharmaceuticals’ new sleep disorder treatment
SK Biopharmaceuticals(CEO Jung-Woo Cho) announced the company completed the New Drug Application(NDA) of SKL-N05(generic name: solriamfetol) that is being jointly developed with Jazz Pharmaceuticals, the world’s top p...
Well-developed incrementally modified drugs over new drugs
Incrementally modified drugs with upgraded features from existing approved products have reportedly played key roles for Korean pharmaceutical companies over new drugs which consumed a ton of funds.
According to the ...
